Terrance P. Coyne
EVP & CFO · Royalty Pharma plc
IndividualSelling only31 10b5-1 trades
- 2025
- Aug 17, 2026
- 17
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Terrance P. Coyne files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Hite - $27.36M in RPRX purchases and sales in the last 12 months
- George W. Lloyd - $9.57M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
- Gregory Norden - $161K in RPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Terrance P. Coyne?
Terrance P. Coyne is a corporate insider, tracked as EVP & CFO of Royalty Pharma plc (RPRX). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Terrance P. Coyne submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Terrance P. Coyne been buying or selling stock?
Recorded transactions: 0 open-market purchases and 31 open-market sales ($33.61M) across all tracked filings.
